Literature DB >> 24688181

Validation of Rules of Two™ as a paradigm for assessing asthma control.

Mark Millard1, Mary Hart1, Sunni Barnes1.   

Abstract

Assessing asthma control at each patient encounter is an essential task to determine pharmacologic requirements. Rules of Two (Ro2) was created from the original 1991 National Asthma Education Program guidelines to determine the need for controller therapy. This study determined the degree of agreement between Ro2 and the Expert Panel Report (EPR-3) definition of "in control" asthma and compared that value with the Asthma Control Test (ACT) in a group of asthmatics for the purpose of validating this tool. Patients with documented asthma were randomized to complete Ro2 or ACT prior to being assessed for asthma control by certified asthma educators using an EPR-3 template. Assessments occurred in either a specialty asthma clinic or at a local health fair. Patients were also queried for their personal assessment of asthma control. The primary statistical methodology employed was the degree of agreement (kappa) between each survey tool and the EPR-3 template. Of 150 patients, 72% did not have their asthma in control, based on the EPR-3 template. Ro2 identified 58% of patients not in control of their asthma, whereas ACT identified 36%, with kappa scores of 0.41 for Ro2 and 0.37 for ACT compared with the EPR-3 template. These were not significantly different. Of the 150 patients, 75% considered their asthma in control based on self-assessments, with a kappa of 0.23. In 14 of 73 ACT questionnaires, scores were not added or were misadded. Eliminating evaluation of static lung function significantly improved both kappa scores of Ro2 and ACT. In conclusion, Ro2 identifies patients with uncontrolled asthma as well as ACT and may be useful to the primary assessing clinician in determining asthma control.

Entities:  

Year:  2014        PMID: 24688181      PMCID: PMC3954651          DOI: 10.1080/08998280.2014.11929063

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  8 in total

1.  Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.

Authors:  E F Juniper; G H Guyatt; R S Epstein; P J Ferrie; R Jaeschke; T K Hiller
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

2.  Comparison of the Asthma in America and Asthma Insight and Management surveys: did asthma burden and care improve in the United States between 1998 and 2009?

Authors:  Robert A Nathan; Eli O Meltzer; Michael S Blaiss; Kevin R Murphy; Dennis E Doherty; Stuart W Stoloff
Journal:  Allergy Asthma Proc       Date:  2011-12-15       Impact factor: 2.587

Review 3.  Defining the responder in asthma therapy.

Authors:  David A Stempel; Anne L Fuhlbrigge
Journal:  J Allergy Clin Immunol       Date:  2005-03       Impact factor: 10.793

4.  Understanding interobserver agreement: the kappa statistic.

Authors:  Anthony J Viera; Joanne M Garrett
Journal:  Fam Med       Date:  2005-05       Impact factor: 1.756

5.  Association of asthma control with health care utilization and quality of life.

Authors:  W M Vollmer; L E Markson; E O'Connor; L L Sanocki; L Fitterman; M Berger; A S Buist
Journal:  Am J Respir Crit Care Med       Date:  1999-11       Impact factor: 21.405

6.  Development of the asthma control test: a survey for assessing asthma control.

Authors:  Robert A Nathan; Christine A Sorkness; Mark Kosinski; Michael Schatz; James T Li; Philip Marcus; John J Murray; Trudy B Pendergraft
Journal:  J Allergy Clin Immunol       Date:  2004-01       Impact factor: 10.793

7.  Relationship of the asthma control test with pulmonary function and exhaled nitric oxide.

Authors:  Toshihiro Shirai; Kazuki Furuhashi; Takafumi Suda; Kingo Chida
Journal:  Ann Allergy Asthma Immunol       Date:  2008-12       Impact factor: 6.347

8.  Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists.

Authors:  Michael Schatz; Christine A Sorkness; James T Li; Philip Marcus; John J Murray; Robert A Nathan; Mark Kosinski; Trudy B Pendergraft; Priti Jhingran
Journal:  J Allergy Clin Immunol       Date:  2006-03       Impact factor: 10.793

  8 in total
  1 in total

Review 1.  Improving the Efficiency of Respiratory Drug Delivery: A Review of Current Treatment Trends and Future Strategies for Asthma and Chronic Obstructive Pulmonary Disease.

Authors:  Ayah Shakshuki; Remigius U Agu
Journal:  Pulm Ther       Date:  2017-06-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.